These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 22022577)

  • 1. Nuclear GRP75 binds retinoic acid receptors to promote neuronal differentiation of neuroblastoma.
    Shih YY; Lee H; Nakagawara A; Juan HF; Jeng YM; Tsay YG; Lin DT; Hsieh FJ; Pan CY; Hsu WM; Liao YF
    PLoS One; 2011; 6(10):e26236. PubMed ID: 22022577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear RXRα and RXRβ receptors exert distinct and opposite effects on RA-mediated neuroblastoma differentiation.
    Girardi CS; Rostirolla DC; Lini FJM; Brum PO; Delgado J; Ribeiro CT; Teixeira AA; Peixoto DO; Heimfarth L; Kunzler A; Moreira JCF; Gelain DP
    Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):317-328. PubMed ID: 30529222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct sensitivity of neuroblastoma cells for retinoid receptor agonists: evidence for functional receptor heterodimers.
    Carpentier A; Balitrand N; Rochette-Egly C; Shroot B; Degos L; Chomienne C
    Oncogene; 1997 Oct; 15(15):1805-13. PubMed ID: 9362447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of GRP75 as an independent favorable prognostic marker of neuroblastoma by a proteomics analysis.
    Hsu WM; Lee H; Juan HF; Shih YY; Wang BJ; Pan CY; Jeng YM; Chang HH; Lu MY; Lin KH; Lai HS; Chen WJ; Tsay YG; Liao YF; Hsieh FJ
    Clin Cancer Res; 2008 Oct; 14(19):6237-45. PubMed ID: 18829503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential changes of retinoid-X-receptor (RXR alpha) and its RAR alpha and PML-RAR alpha partners induced by retinoic acid and cAMP distinguish maturation sensitive and resistant t(15;17) promyelocytic leukemia NB4 cells.
    Duprez E; Lillehaug JR; Gaub MP; Lanotte M
    Oncogene; 1996 Jun; 12(11):2443-50. PubMed ID: 8649786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinoic acid induces differentiation in neuroblastoma via ROR1 by modulating retinoic acid response elements.
    Illendula A; Fultang N; Peethambaran B
    Oncol Rep; 2020 Sep; 44(3):1013-1024. PubMed ID: 32705280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydropyrimidinase-like protein 3 expression is negatively regulated by MYCN and associated with clinical outcome in neuroblastoma.
    Tan F; Wahdan-Alaswad R; Yan S; Thiele CJ; Li Z
    Cancer Sci; 2013 Dec; 104(12):1586-92. PubMed ID: 24011394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma.
    Lovén J; Zinin N; Wahlström T; Müller I; Brodin P; Fredlund E; Ribacke U; Pivarcsi A; Påhlman S; Henriksson M
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1553-8. PubMed ID: 20080637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of retinoid receptors during the retinoic acid-induced neuronal differentiation of human embryonal carcinoma cells.
    Cheung WM; Chu PW; Lung CH; Ip NY
    J Neurochem; 2000 Jul; 75(1):34-40. PubMed ID: 10854244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma.
    Sainero-Alcolado L; Mushtaq M; Liaño-Pons J; Rodriguez-Garcia A; Yuan Y; Liu T; Ruiz-Pérez MV; Schlisio S; Bedoya-Reina O; Arsenian-Henriksson M
    J Exp Clin Cancer Res; 2022 Jul; 41(1):226. PubMed ID: 35850708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinoic acid induced downregulation of MYCN is not mediated through changes in Sp1/Sp3.
    Kanemaru KK; Tuthill MC; Takeuchi KK; Sidell N; Wada RK
    Pediatr Blood Cancer; 2008 Apr; 50(4):806-11. PubMed ID: 17554788
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoactive intestinal peptide decreases MYCN expression and synergizes with retinoic acid in a human MYCN-amplified neuroblastoma cell line.
    Chevrier L; Meunier AC; Cochaud S; Muller JM; Chadéneau C
    Int J Oncol; 2008 Nov; 33(5):1081-9. PubMed ID: 18949372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A RA-dependent, tumour-growth suppressive transcription complex is the target of the PML-RARalpha and T18 oncoproteins.
    Zhong S; Delva L; Rachez C; Cenciarelli C; Gandini D; Zhang H; Kalantry S; Freedman LP; Pandolfi PP
    Nat Genet; 1999 Nov; 23(3):287-95. PubMed ID: 10610177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of Wnt-5a gene is associated with high-risk neuroblastoma.
    Blanc E; Roux GL; Bénard J; Raguénez G
    Oncogene; 2005 Feb; 24(7):1277-83. PubMed ID: 15592517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinoic acid induces proteasome-dependent degradation of retinoic acid receptor alpha (RARalpha) and oncogenic RARalpha fusion proteins.
    Zhu J; Gianni M; Kopf E; Honoré N; Chelbi-Alix M; Koken M; Quignon F; Rochette-Egly C; de Thé H
    Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14807-12. PubMed ID: 10611294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High glucose-induced repression of RAR/RXR in cardiomyocytes is mediated through oxidative stress/JNK signaling.
    Singh AB; Guleria RS; Nizamutdinova IT; Baker KM; Pan J
    J Cell Physiol; 2012 Jun; 227(6):2632-44. PubMed ID: 21882190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p19-INK4d inhibits neuroblastoma cell growth, induces differentiation and is hypermethylated and downregulated in MYCN-amplified neuroblastomas.
    Dreidax D; Bannert S; Henrich KO; Schröder C; Bender S; Oakes CC; Lindner S; Schulte JH; Duffy D; Schwarzl T; Saadati M; Ehemann V; Benner A; Pfister S; Fischer M; Westermann F
    Hum Mol Genet; 2014 Dec; 23(25):6826-37. PubMed ID: 25104850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
    Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
    Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcription factor activating protein 2 beta (TFAP2B) mediates noradrenergic neuronal differentiation in neuroblastoma.
    Ikram F; Ackermann S; Kahlert Y; Volland R; Roels F; Engesser A; Hertwig F; Kocak H; Hero B; Dreidax D; Henrich KO; Berthold F; Nürnberg P; Westermann F; Fischer M
    Mol Oncol; 2016 Feb; 10(2):344-59. PubMed ID: 26598443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MYCN inhibitor BGA002 restores the retinoic acid response leading to differentiation or apoptosis by the mTOR block in MYCN-amplified neuroblastoma.
    Lampis S; Raieli S; Montemurro L; Bartolucci D; Amadesi C; Bortolotti S; Angelucci S; Scardovi AL; Nieddu G; Cerisoli L; Paganelli F; Valente S; Fischer M; Martelli AM; Pasquinelli G; Pession A; Hrelia P; Tonelli R
    J Exp Clin Cancer Res; 2022 Apr; 41(1):160. PubMed ID: 35490242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.